References
- Mózes FE, Lee JA, Selvaraj EA, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71(5):1006–1019. doi:10.1136/gutjnl-2021-324243.
- Hagström H, Talbäck M, Andreasson A, et al. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J Hepatol. 2020;73(5):1023–1029. doi:10.1016/j.jhep.2020.06.007.
- Bradley CR, Cox EF, Palaniyappan N, et al. Variability of noninvasive MRI and biological markers in compensated cirrhosis: insights for assessing disease progression. Eur Radiol Exp. 2022;6(1):52. doi:10.1186/s41747-022-00303-y.
- Åsberg A, Bolann BJ. Calculating the coefficient of variation from duplicate measurements: a new method. J Appl Lab Med. 2023;8(1):220–222. doi:10.1093/jalm/jfac098.
- Carobene A, Marino I, Coşkun A, et al. The EuBIVAS project: within- and between-Subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clin Chem. 2017;63(9):1527–1536. doi:10.1373/clinchem.2017.275115.
- Aarsand AK, Díaz-Garzón J, Fernandez-Calle P, et al. The EuBIVAS: within- and between-Subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clin Chem. 2018;64(9):1380–1393. doi:10.1373/clinchem.2018.288415.
- Røraas T, Støve B, Petersen PH, et al. Biological variation: the effect of different distributions on estimated within-Person variation and reference change values. Clin Chem. 2016;62(5):725–736. doi:10.1373/clinchem.2015.252296.